NACE 86940 in Halen · BE. Official registry identity, filed financial evidence and a rounded indicative valuation range on one indexed company profile.
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on filed company accountsCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
You have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The valuation for NURZA combines official public company figures with Upswitch sector calibration. The owner can sharpen it with their own figures and context into a full, defensible valuation curve.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
NURZA, a business in NACE sector 86940, is registered at an address in Halen, Belgium. The company was founded in 2020, incorporated as a Besloten Vennootschap.
NURZA is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0757968886 and VAT number BE0757968886. This profile consolidates Kbo Open Data, NBB/CBSO annual accounts into one indexable company dossier.
Companies in this NACE 86940 band file annual accounts with NBB/CBSO.
Across the 2024-2025 window revenue has more than doubled, moving from €10,726,289 to €18,184,198. EBITDA for 2025 comes in at €671,229.
An indicative valuation band is available for NURZA, based on filed company accounts. A free account lets the visitor refine it with current data and build a five-year outlook.
The most recent annual filing covers 2025 (period end 2025-09-30).
The data on this page is a public, point-in-time projection of NURZA's regulator-filed footprint, built to support indicative valuation bands, sellability context, and acquisition research.
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €18,184,198 | €671,229 | €4,297,892 | €545,948 | - |
| 202430 Sept 2024 | €10,726,289 | €588,967 | €3,551,345 | €301,818 | - |
NURZA was founded in 2020 and is registered with Belgian Crossroads Bank for Enterprises (KBO), incorporated as a Besloten Vennootschap.
NURZA is registered under NACE 86940: NACE 86940. That places the business within the Belgian cluster for this activity.
According to the company registry, NURZA is based in Halen, BE.
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-09-30), publicly available via Belgian Crossroads Bank for Enterprises (KBO).
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for NURZA may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Public profiles for peers in the same industry and country. Click through to compare filings and indicative valuations.
